×
0.000390927909048379 0.00500515896666854 0.0189760252244631 0.017341818391556 0.0222188042732907 0.0388364447349701 0.0305116028685137 0.0534033158377072
Stockreport

Cara Therapeutics breaks out, up 13% [Seeking Alpha]

CARA THERAPEUTICS (CARA)  More Company Research Source: Seeking Alpha
Last cara therapeutics earnings: 11/2 04:01 pm Check Earnings Report
PDF Cara Therapeutics breaks out, up 13%Cara Therapeutics (CARA+13%) breaks out of consolidation on more than a 4x surge in volume. No particular news accounts for the action although Motley Foolpublished an article this morning supporting a bullish thesis on lead candidate CR845. The piece is basically a summary of previously released information.CR845, a peripherally acting kappa opioid receptor agonist, is being developed for the treatment of acute and chronic pain. Its value proposition is opioid-like analgesia without the respiratory depression or intestinal tract inhibition (constipation).See all stocks on the move »Now read:My List Of The Best Early Stage Biotechs For 2018 » [Read more]

IMPACT SNAPSHOT EVENT TIME: CARA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS